Skip to search formSkip to main content

TCV 309

Known as: TCV-309 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Platelet-activating factor (PAF) is a potent inflammatory lipid mediator in peripheral tissues. However, its role in mediation of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
We investigated the role of platelet-activating factor (PAF) as a priming signal for cytokine-induced neutrophil chemoattractant… Expand
Is this relevant?
1998
1998
Infiltration of eosinophils into the lung lumen is a hallmark of allergic asthmatic inflammation. To reach the lung lumen… Expand
Is this relevant?
1996
1996
In a prospective randomized, double-blind, placebo-controlled clinical study, the safety and efficacy of the platelet-activating… Expand
Is this relevant?
1993
1993
1. The present study was conducted in order to examine the effects of the platelet-activating factor (PAF) antagonist, TCV-309… Expand
Is this relevant?
1993
1993
OBJECTIVES The aims were to confirm that platelet activating factor is released during reperfusion after global ischaemia in… Expand
Is this relevant?
1992
1992
Pharmacological profiles of a novel specific platelet activating factor (PAF) antagonist, TCV-309 (3-bromo-5-[N-phenyl-N-[2-[2… Expand
Is this relevant?
1992
1992
TCV-309 potently and specifically inhibited the diverse biological actions of PAF such as platelet aggregation, hypotension… Expand
Is this relevant?
1992
1992
The importance of platelet activating factor in acute pancreatitis was examined by determining the tissue content of endogenous… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?